XOMA Corporation XOMA US — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by XOMA Corporation in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about XOMA Corporation's us — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is XOMA Corporation's US — revenue?
- XOMA Corporation (XOMA) reported US — revenue of $5.62M in Q1 2026.
- How has XOMA Corporation's US — revenue changed year-over-year?
- XOMA Corporation's US — revenue decreased by 7.8% year-over-year, from $6.1M to $5.62M.
- What is the long-term trend for XOMA Corporation's US — revenue?
- Over 4 years (2021 to 2025), XOMA Corporation's US — revenue has grown at a 72.5% compound annual growth rate (CAGR), from $2.61M to $23.09M.
- What does US — revenue mean?
- This metric represents the total gross income generated from royalty streams and milestone payments derived from therapeutic assets within the United States market. It reflects the company's ability to monetize its portfolio of acquired economic rights from biotechnology and pharmaceutical partners operating in this region. Growth in this figure indicates successful commercialization or clinical advancement of the underlying drug candidates held in the company's royalty portfolio.